TERN (TERN)
Terns Pharmaceuticals, Inc.
NASDAQ:TERNHealthcare · Biotechnology
Mkt Cap-
Float115.2M
O/S-
Inst Own-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$96.21M
Total Assets$1.03B
Free Cash Flow-$82.18M
Debt & Equity
Debt 0%
Equity 100%
Total Debt$919K
Total Equity$1.01B
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in TERN's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$1.03B
Liabilities$18.55M
Accounts Receivable$0
Accounts Payable$1.72M
Inventory$0
PP&E (Net)$884K
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $1M | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $195K | $65K |
| Gross Profit | $0 | $0 | $0 | $0 | $1M | $0 | -$195K | -$65K |
| Gross Margin | - | - | - | - | 100.0% | - | - | - |
| Research and Development | $77.89M | $70.11M | $63.5M | $39.62M | $31.31M | $28.03M | $61.53M | $14.55M |
| Selling, General, and Administrative | $32.23M | $31.76M | $39.06M | $22.41M | $19.55M | $9M | $8.66M | $3.9M |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $154K | $38K |
| Total Operating Expenses | $110.12M | $101.87M | $102.56M | $62.03M | $50.86M | $37.02M | $70.2M | $18.45M |
| Operating Income (EBIT) | -$110.12M | -$101.87M | -$102.56M | -$62.03M | -$49.86M | -$37.02M | -$70.2M | -$18.45M |
| Operating Margin | - | - | - | - | -4986.0% | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $14.59M | $13.29M | $12.9M | $2.11M | $170K | $55K | $1.2M | $332K |
| Other Income (Expense) | $14.5M | $13.28M | $12.59M | $2.04M | $210K | $7.97M | $1.36M | $370K |
| Income Before Tax (EBT) | -$95.63M | -$88.59M | -$89.97M | -$59.99M | -$49.65M | -$29.06M | -$68.84M | -$18.09M |
| Income Tax Expense | $581K | $260K | $239K | $358K | $508K | $813K | -$20K | -$67K |
| Net Income | -$96.21M | -$88.85M | -$90.21M | -$60.34M | -$50.16M | -$29.35M | -$68.82M | -$17.71M |
| Net Income Margin | - | - | - | - | -5015.8% | - | - | - |
| Supplementary Data | ||||||||
| EPS | -1.03 | -1.12 | -1.27 | -1.67 | -1.98 | -1.61 | -2.74 | -0.74 |
| Diluted EPS | -1.03 | -1.12 | -1.27 | -1.67 | -1.98 | -1.61 | -2.74 | -0.74 |
| Weighted Average OS | 93.17M | 79.51M | 71.26M | 36.03M | 25.27M | 25.13M | 25.10M | 23.97M |
| EBITDA | -$95.13M | -$87.7M | -$89.09M | -$58.95M | -$49.14M | -$36.63M | -$68.64M | -$18.39M |
| EBITDA Margin | - | - | - | - | -4913.8% | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $524.75M | $161.44M | $79.93M | $143.24M | $47.7M | $74.85M | $12.33M | $82.52M |
| Short-Term Investments | $494.24M | $196.72M | $183.51M | $139.88M | $118.28M | $0 | $7.32M | $4.36M |
| Cash and Short-Term Investments | $1.02B | $358.16M | $263.44M | $283.11M | $165.98M | $74.85M | $19.65M | $86.88M |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $12.72M | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $5.21M | $3.94M | $3.99M | $2.07M | $0 | $2.14M | $461K | $162K |
| Total Current Assets | $1.02B | $362.11M | $267.43M | $285.19M | $166.93M | $90.87M | $22.22M | $88.48M |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $884K | $1.47M | $1.03M | $1.8M | $1.05M | $1.18M | $961K | $261K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $350K | $56K | $37K | $94K | $246K | $719K | $335K |
| Total Long-Term Assets | $884K | $1.82M | $1.08M | $1.84M | $1.14M | $1.42M | $1.68M | $596K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $1.03B | $363.93M | $268.52M | $287.03M | $168.07M | $92.29M | $23.9M | $89.07M |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $1.72M | $2.15M | $2.52M | $1.65M | $2.13M | $935K | $1.64M | $914K |
| Short-Term Debt | $0 | $428K | $0 | $0 | $0 | $12.88M | $0 | $0 |
| Current Income Tax Payable | $1.7M | $1.49M | $1.21M | $1.07M | $0 | $657K | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $836K | $0 | $0 |
| Other Current Liabilities | $7.37M | $8.37M | $5.96M | $185K | $2.29M | $6.68M | $2.1M | $127K |
| Total Current Liabilities | $16.41M | $15.65M | $11.94M | $8.47M | $6.82M | $22.82M | $4.95M | $2.38M |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $787K | $0 | $345K | $142K |
| Other Long-Term Liabilities | $1.7M | $1.49M | $1.21M | $1.07M | $160K | $877K | $285K | $14.32M |
| Total Long-Term Liabilities | $2.14M | $2.41M | $1.21M | $1.61M | $947K | $877K | $630K | $14.47M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $18.55M | $18.06M | $13.15M | $10.08M | $7.77M | $23.7M | $5.58M | $16.84M |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $186.03M | $94.97M | $94.97M |
| Common Stock | $11K | $9K | $6K | $5K | $3K | $0 | $0 | $0 |
| Retained Earnings | -$517.69M | -$421.48M | -$332.63M | -$242.42M | -$182.07M | -$131.91M | -$91.86M | -$23.25M |
| Comprehensive Income & Other | $260K | -$279K | -$19K | -$822K | -$338K | -$124K | -$106K | $59K |
| Other Stockholders' Equity | $1.52B | $767.34M | $587.99M | $519.36M | $342.37M | $200.51M | $96.07M | $95.48M |
| Total Equity | $1.01B | $345.87M | $255.37M | $276.94M | $160.3M | $68.59M | $4.21M | $72.23M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $14.12M | $14.32M |
| Total Liabilities and Equity | $1.03B | $363.93M | $268.52M | $287.03M | $168.07M | $92.29M | $9.79M | $89.07M |
| Supplementary Data | ||||||||
| Total Debt | $919K | $1.35M | $603K | $1.21M | $0 | $12.88M | $0 | $0 |
| Net Debt | -$523.83M | -$160.09M | -$79.32M | -$142.03M | -$47.7M | -$61.97M | -$12.33M | -$82.52M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Operating Activities | ||||||||
| Net Income | -$96.21M | -$88.85M | -$90.21M | -$60.34M | -$50.16M | -$40.57M | -$68.82M | -$18.02M |
| Depreciation & Amortization | $501K | $896K | $881K | $1.03M | $512K | $394K | $195K | $65K |
| Deferred Income Tax | $511K | $23K | $141K | $392K | $219K | $693K | -$94K | $307K |
| Stock-Based Compensation | $13.4M | $15.63M | $25.54M | $10.77M | $8.15M | $1.69M | $668K | $234K |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$512K | -$367K | $1.15M | -$722K | $1.73M | -$1.15M | $722K | $488K |
| Other Working Capital | $191K | $4.75M | $326K | -$315K | -$3.15M | $6.21M | $1.15M | -$840K |
| Total Working Capital Change | -$321K | $4.38M | $1.48M | -$1.04M | -$1.43M | $5.06M | $1.87M | -$352K |
| Other Non-Cash Items | -$58K | -$2.09M | -$5.21M | $81K | $879K | $2.92M | -$40K | -$307K |
| Net Cash from Operating | -$82.18M | -$70.02M | -$67.39M | -$49.11M | -$41.83M | -$29.81M | -$66.22M | -$18.07M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | -$42K | -$52K | -$275K | -$340K | -$584K | -$900K | -$244K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $12.04M |
| Purchases of Investments | -$405.04M | -$169.94M | -$275.78M | -$139.73M | -$166.3M | -$715K | -$58.38M | -$6.95M |
| Sales of Investments | $107M | $157.57M | $237.85M | $117.73M | $46.94M | $7.99M | $55.43M | $2.42M |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$5K |
| Net Cash from Investing | -$298.04M | -$12.41M | -$37.99M | -$22.27M | -$119.7M | $6.69M | -$3.86M | -$4.78M |
| Financing Activities | ||||||||
| Debt Repaid | - | - | - | - | $12.88M | -$16.88M | -$58K | -$58K |
| Common Stock Issuance | $743.75M | $162.31M | $41.61M | $167.25M | $136.36M | $0 | $0 | $87.66M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$235K | $1.68M | $340K | -$158K | $10.91M | -$738K | $4K | $12.05M |
| Net Cash from Financing | $743.51M | $164M | $41.95M | $167.09M | $134.39M | $85.52M | $62K | $99.76M |
| Forex Effect | $16K | -$56K | $117K | -$178K | -$25K | $80K | -$131K | $103K |
| Net Change in Cash | $363.31M | $81.51M | -$63.31M | $95.54M | -$27.16M | $62.48M | -$70.15M | $77.02M |
| Supplementary Data | ||||||||
| Operating Cash Flow | -$82.18M | -$70.02M | -$67.39M | -$49.11M | -$41.83M | -$29.81M | -$66.22M | -$18.07M |
| Capital Expenditure | $0 | -$42K | -$52K | -$275K | -$340K | -$584K | -$900K | -$244K |
| Free Cash Flow | -$82.18M | -$70.06M | -$67.44M | -$49.38M | -$42.17M | -$30.39M | -$67.12M | -$18.32M |
| Cash at Beginning | $161.44M | $79.93M | $143.24M | $47.7M | $74.85M | $12.38M | $82.52M | $5.5M |
| Cash at End | $524.75M | $161.44M | $79.93M | $143.24M | $47.7M | $74.85M | $12.38M | $82.52M |